Dale F Gruber

Title: Dale F Gruber: Innovator in Cell Culture Technology

Introduction

Dale F Gruber is a notable inventor based in Grand Island, NY (US). She has made significant contributions to the field of cell culture technology, holding a total of 8 patents. Her work focuses on developing innovative methods and media for cell growth and transfection.

Latest Patents

One of her latest patents is titled "Culture medium for cell growth and transfection." This invention is directed towards cell culture media that facilitate the introduction of macromolecules, such as nucleic acid molecules, into eukaryotic cells. The media allow for the further culturing of cells containing these introduced materials. This invention simplifies the process by eliminating the need to change the cell culture medium for different procedures, thus providing efficient and high-throughput methods for transforming and transfecting cells.

Another significant patent is "Serum-free mammalian cell culture medium, and uses thereof." This invention presents a cell culture medium formulation that supports the in vitro cultivation of mammalian cells, particularly in suspension. The media comprise a basal medium and a polyanionic compound, which enhances the growth of mammalian cells in suspension culture. This innovation increases the expression of recombinant proteins and virus production in cultured cells.

Career Highlights

Dale F Gruber has worked with prominent companies in the biotechnology sector, including Life Technologies Corporation and Invitrogen Corporation. Her experience in these organizations has contributed to her expertise in cell culture technologies.

Collaborations

Throughout her career, she has collaborated with notable individuals such as David Epstein and Glenn Godwin. These collaborations have further enriched her work and innovations in the field.

Conclusion

Dale F Gruber's contributions to cell culture technology have significantly advanced the field, making her a prominent figure among inventors. Her innovative patents continue to influence research and applications in biotechnology.